Pharmatherapeutical approaches in insomniac patients with cardiac diseases and after heart transplantation;Pharmakotherapeutische behandlungsstrategien der insomnie bei patienten mit kardialen erkrankungen und nach herztransplantation

Zeitschrift fur Kardiologie

Volumn 90, Issue 10, 2001, Pages 717-728

  Wobrock, T ^a   Schwaab, B ^b   Bohm M ^a   Schafers H J ^a   Wanke, K ^a   Supprian, T ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Curschmann Klinik   (Germany)

Author keywords

Heart disease; Hypnotics; Insomnia; Pharmacotherapy; Transplantation

Indexed keywords

ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROTIZOLAM; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DIGITALIS; DIGOXIN; FLUNITRAZEPAM; FLUOXETINE; FLURAZEPAM; HYPNOTIC SEDATIVE AGENT; LOPRAZOLAM; LORMETAZEPAM; MAPROTILINE; MELPERONE; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; NITRAZEPAM; NONSTEROID ANTIINFLAMMATORY AGENT; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TRAZODONE; TRIAZOLAM; UNINDEXED DRUG; VENLAFAXINE; ZOPICLONE;

DRUG CHOICE; DRUG INDICATION; DRUG METABOLISM; DRUG SAFETY; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; INSOMNIA; POSTOPERATIVE PERIOD; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ARRHYTHMIA; DEPRESSIVE DISORDER; DRUG INTERACTIONS; HEART DISEASES; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HISTAMINE ANTAGONISTS; HUMANS; HYPERTENSION; HYPNOTICS AND SEDATIVES; PHYTOTHERAPY; PLANT PREPARATIONS; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0034778604     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920170091     Document Type: Review

References (38)

1. A case of trazodone-induced ventricular tachycardia
2. The effects of imipramine, mianserine and trazodone on the chronotropic, inotropic and coronary vascular response in the isolated perfused rat heart
3. Empfehlungen zu diagnostik und therapie der insomnie
4. Antidepressant efficiacy and cardiac safety of trimipramine in patients with mild heart disease
5. The importance of depression following myocardial infarction
6. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality
7. Arzneimittelinteraktionen mit antidepressiva
8. The diagnosis and management of insomnia
9. Review of the cardiovascular effects of heterocyclic antidepressants
10. A comparative assessment of the risks and benefits of zopiclone: A review of 15 years clinical experience
11. Zaleplon - Ein neues hypnotikum gegen einschlafstörungen
12. Treatment of primary insomnia with trimipramine: An alternative to benzodiazepine hypnotics?
13. Meta-analysis of benzodiazepine use in the treatment of insomnia
14. Clinical efficiacy of mirtazapine: A review of meta-analysis of pooled data
15. Psychiatrisch relevante nebenwirkungen der nichtpsychopharmakologischen pharmakotherapie
16. Zolpidem und zopiclon
17. Psychopathology in heart transplant candidates
18. Wirksamkeit und verträglichkeit von melperon bei gerontopsychiatrischen patienten mit insomnie - Eine schlafpolygraphische doppelblind-studie vs. lormetazepam
19. Limitations on the use of benzodiazepines in anxiety and insomnia: Are they justified?
20. Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants
21. Cytochromes in psychopharmacology
22. Phytopharmaka zur behandlung von schlafstörungen
23. Die bedeutung des hepatischen cytochrom-P-450-systems für die psychopharmakologie
24. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
25. Considerations for the use of antidepressants in patients with cardiovascular disease
26. Acute heart transplant rejection due to Saint John's word
27. Nortriptyline treatment of depressed cardiac transplant recipients
28. Chronifizierung von schlafbeschwerden
29. Unterschiede in den wirkungen von antidepressiva auf den schlaf
30. Use of tricyclic antidepressants in patients with cardiac conduction disturbances
31. Update in the pharmcotherapy of depression
32. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770)
33. Psychopharmacology and neuropsychiatric syndromes in organ transplantation
34. Psychopharmacologic issues in organ tranplantation - Part 2: Psychopharmacologic medications
35. Electrocardiographic changes in patients receiving neuroleptic medication
36. Pharmakotherapie bei einem patienten nach herztransplantation mit schlafstörung und parästhesien
37. Herbal remedies in psychiatric practice
38. QT-prolonging drugs: Mechanism and clinical relevance of their arhythmogenic hazards